Sionna Therapeutics (SION) Enterprise Value (2024 - 2026)

Sionna Therapeutics has disclosed Enterprise Value across 3 years of filings, most recently posting -$216.2 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$216.2 million, up 19.85% year-over-year; the trailing twelve-month figure through Mar 2026 was -$216.2 million (up 19.85% YoY), and the FY2025 annual result was -$235.9 million, down 59.88% from the prior year.
• Enterprise Value came in at -$216.2 million for Q1 2026 at Sionna Therapeutics, up from -$235.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$35.7 million in Q3 2024 to a low of -$269.7 million in Q1 2025.
• The 3-year median for Enterprise Value is -$216.2 million (2026), against an average of -$171.4 million.
• Across the five-year window, Enterprise Value slumped 594.65% in 2025 and gained 19.85% in 2026, its largest moves.
• Sionna Therapeutics' Enterprise Value stood at -$147.5 million in 2024, then tumbled by 59.88% to -$235.9 million in 2025, then climbed by 8.37% to -$216.2 million in 2026.
• The last three Enterprise Value figures came in at -$216.2 million (Q1 2026), -$235.9 million (Q4 2025), and -$248.3 million (Q3 2025), per Business Quant data.